Marzena Fandzloch

发表

Ruthenium(III) complexes with monodentate 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one: Structural characterization, interaction with DNA and proteins

A. Wojtczak, J. M. Salas, J. Wiśniewska, 2016 .

Interaction of ruthenium(II) and ruthenium(III) ions with 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one

A. Wojtczak, J. Sitkowski, I. Łakomska, 2014 .

Application of 1,2,4-triazolo[1,5-a]pyrimidines for the design of coordination compounds with interesting structures and new biological properties

I. Łakomska, Marzena Fandzloch, M. Fandzloch, 2016 .

A vanadium(IV) pyrazolate metal-organic polyhedron with permanent porosity and adsorption selectivity.

J. Navarro, A. Augustyniak, I. Łakomska, 2015, Chemical communications.

Biomimetic 1-Aminocyclopropane-1-Carboxylic Acid Oxidase Ethylene Production by MIL-100(Fe) Based Materials.

J. Navarro, E. Barea, C. Maldonado, 2019, ACS applied materials & interfaces.

The reduction of ruthenium(III) complexes with triazolopyrimidine ligands by ascorbic acid and mechanistic insight into their action in anticancer therapy

J. Wiśniewska, I. Łakomska, Marzena Fandzloch, 2019, Inorganica Chimica Acta.

Bioactive nanoglasses and xerogels (SiO2–CaO and SiO2–CaO–P2O5) as promising candidates for biomedical applications

A. Lukowiak, K. Roszek, A. Augustyniak, 2022, Ceramics International.

Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.

A. Wojtczak, J. M. Salas, J. Wiśniewska, 2017, Journal of inorganic biochemistry.

Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.

J. Jezierska, T. Lis, I. Łakomska, 2013, Dalton transactions.

Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.

A. Wojtczak, J. Wiśniewska, J. Sitkowski, 2020, Dalton transactions.

In search of new anticancer drug – Dimethylsulfoxide ruthenium(III) complex with bulky triazolopyrimidine derivative and preliminary studies towards understanding the mode of action

J. M. Salas, J. Wiśniewska, L. Dobrzańska, 2018 .

Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties

J. Wiśniewska, T. Jędrzejewski, L. Dobrzańska, 2019, JBIC Journal of Biological Inorganic Chemistry.

Cu-HKUST-1 and Hydroxyapatite–The Interface of Two Worlds toward the Design of Functional Materials Dedicated to Bone Tissue Regeneration

J. Wiśniewska, K. Roszek, Anna Jaromin, 2023, ACS biomaterials science & engineering.

Cation-Exchange in Metal-Organic Framework as a Strategy to Obtain New Material for Ascorbic Acid Detection

A. Lukowiak, R. Szukiewicz, Marzena Fandzloch, 2022, Nanomaterials.

New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application.

P. Paneth, J. Wiśniewska, T. Jędrzejewski, 2021, Dalton transactions.

Use of 1,2,4-triazolo[1,5-a]pyrimidines to design new “piano-stool” ruthenium(II) compounds

A. Wojtczak, J. Sitkowski, I. Łakomska, 2016 .

Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.

J. Wietrzyk, J. Sitkowski, I. Łakomska, 2012, Journal of inorganic biochemistry.

Highly Sensitive, Multiparametric Thermal History Phosphor Based on An Eu(BTC) Architecture

L. Marciniak, Marzena Fandzloch, M. Szymczak, 2024, Advanced Functional Materials.

Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.

J. Sitkowski, I. Łakomska, Marzena Fandzloch, 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.